-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $19

Benzinga·05/07/2025 17:39:03
Listen to the news
RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and lowers the price target from $23 to $19.